Hiv Infected clinical trials

Explore recruiting hiv infected clinical trials.

Recruiting hiv infected studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hiv Infected trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children with HIV infection aged 2 to <15 years old

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)

Spain, Ireland, Netherlands, Belgium, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Implementation of Out-of-HOspital administration of the Long-Acting combination cabotegravir+rilpivirine as an optional therapy in HIV-Infected patients from Spain. Acceptability, appropriateness, feasibility and satisfaction. The HOLA Study.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment regimen in HIV-infected patients with metabolic liver disease who maintain undetectable HIV viral load

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Immunogenicity of 9-valent HPV vaccine in immunocompromised children and adolescents

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Inhibiting the anti-apoptotic factor, BCL-2, at the time of ART initiation to promote apoptosis of HIV-infected cells and restrict the seeding of the HIV reservoir: An investigator-initiated randomised, controlled, open-label clinical trial (The INITIATE Study)

Denmark, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Hiv Infected trials by city

Hiv Infected in Toronto Hiv Infected in Vancouver Hiv Infected in Montreal Hiv Infected in Calgary Hiv Infected in Edmonton Hiv Infected in Ottawa Hiv Infected in Winnipeg Hiv Infected in Quebec City Hiv Infected in Hamilton Hiv Infected in Kitchener Hiv Infected in London Hiv Infected in Halifax Hiv Infected in New York Hiv Infected in Los Angeles Hiv Infected in Chicago Hiv Infected in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease